Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf M Mesters

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|June 14, 2003
Identification of distinct sequences in human blood coagulation factor Xa and prothrombin essential for substrate and cofactor recognition in the prothrombinase complexSubramanian Yegneswaran, Rolf M Mesters, John H Griffin
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 25, 2009
Lymphangiogenesis in cancer: current perspectivesRüediger Liersch, Christoph Biermann, Rolf M Mesters, et al.
Oncology Reports|October 10, 2003
Rituximab in combination with platinum-containing chemotherapy in patients with relapsed or primary refractory diffuse large B-cell lymphomaRalf Bieker, Torsten Kessler, Wolfgang E Berdel, et al.
The Journal of Biological Chemistry|August 28, 2004
Prothrombin residues 473-487 contribute to factor Va binding in the prothrombinase complexSubramanian Yegneswaran, Rolf M Mesters, José A Fernández, et al.
International Journal of Oncology|October 19, 2012
Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicatorRuediger Liersch, Satoshi Hirakawa, Wolfgang E Berdel, et al.
Current Drug Targets|February 20, 2007
Vascular endothelial growth factor and its receptor as drug targets in hematological malignanciesTorsten Kessler, Frauke Fehrmann, Ralf Bieker, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 25, 2009
Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancyIris Appelmann, Rüediger Liersch, Torsten Kessler, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 25, 2009
Compounds in clinical Phase III and beyondTorsten Kessler, Michael Bayer, Christian Schwöppe, et al.
European Journal of Haematology|October 6, 2007
Downregulation of neuropilin-1 in patients with acute myeloid leukemia treated with thalidomideMichael Kreuter, Martin Steins, Katja Woelke, et al.
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Signal transduction pathways as novel therapy targets in lung cancerNiels Reinmuth, Rolf M Mesters, Ralf Bieker, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|June 14, 2003
Identification of distinct sequences in human blood coagulation factor Xa and prothrombin essential for substrate and cofactor recognition in the prothrombinase complexSubramanian Yegneswaran, Rolf M Mesters, John H Griffin
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 25, 2009
Lymphangiogenesis in cancer: current perspectivesRüediger Liersch, Christoph Biermann, Rolf M Mesters, et al.
Oncology Reports|October 10, 2003
Rituximab in combination with platinum-containing chemotherapy in patients with relapsed or primary refractory diffuse large B-cell lymphomaRalf Bieker, Torsten Kessler, Wolfgang E Berdel, et al.
The Journal of Biological Chemistry|August 28, 2004
Prothrombin residues 473-487 contribute to factor Va binding in the prothrombinase complexSubramanian Yegneswaran, Rolf M Mesters, José A Fernández, et al.
International Journal of Oncology|October 19, 2012
Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicatorRuediger Liersch, Satoshi Hirakawa, Wolfgang E Berdel, et al.
Current Drug Targets|February 20, 2007
Vascular endothelial growth factor and its receptor as drug targets in hematological malignanciesTorsten Kessler, Frauke Fehrmann, Ralf Bieker, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 25, 2009
Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancyIris Appelmann, Rüediger Liersch, Torsten Kessler, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 25, 2009
Compounds in clinical Phase III and beyondTorsten Kessler, Michael Bayer, Christian Schwöppe, et al.
European Journal of Haematology|October 6, 2007
Downregulation of neuropilin-1 in patients with acute myeloid leukemia treated with thalidomideMichael Kreuter, Martin Steins, Katja Woelke, et al.
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Signal transduction pathways as novel therapy targets in lung cancerNiels Reinmuth, Rolf M Mesters, Ralf Bieker, et al.
Pageof 7